Uninephrectomy of diabetic OVE26 mice greatly accelerates albuminuria, fibrosis, inflammatory cell infiltration and changes in gene expression

Nephron - Experimental Nephrology

Volumn 119, Issue 1, 2011, Pages

  Zheng, Shirong ^a   Huang, Yun ^a   Yang, Lu ^a   Chen, Teresa ^a   Xu, Jianxiang ^a   Epstein, Paul N ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Albuminuria; Diabetic nephropathy; Inflammation; Interstitial fibrosis; Microarray

Indexed keywords

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANONICAL ANALYSIS; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; ELECTROCHEMICAL DETECTION; FEMALE; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; KIDNEY INJURY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; UNINEPHRECTOMY;

ALBUMINURIA; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FIBROSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLOMERULAR FILTRATION RATE; HYPERTROPHY; KIDNEY; MICE; MICE, INBRED STRAINS; MONOCYTES; NEPHRECTOMY;

EID: 79958065612     PISSN: 16602129     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000327586     Document Type: Article

References (27)

1. Breyer MD, Qi Z, Tchekneva E: Diabetic nephropathy: Leveraging mouse genetics. Curr Opin Nephrol Hypertens 2006; 15: 227-232.
2. Breyer MD: Stacking the deck for drug discovery in diabetic nephropathy: In search of an animal model. J Am Soc Nephrol 2008; 19: 1623-1624.
3. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B: Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007; 18: 539-550. (Pubitemid 46193319)
4. Kanetsuna Y, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, Takahashi T: Deficiency of endothelial nitric oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol 2007; 170: 1473-1484. (Pubitemid 47339294)
5. Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T: Mouse models of diabetic nephropathy. J Am Soc Nephrol 2009; 20: 2503-2512.
6. Zheng S, Noonan WT, Metreveli NS, Coventry S, Kralik PM, Carlson EC, Epstein PN: Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 2004; 53: 3248-3257. (Pubitemid 39564502)
7. Zheng S, Carlson EC, Yang L, Kralik PM, Huang Y, Epstein PN: Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. J Am Soc Nephrol 2008; 19: 2077-2085.
8. Levine DZ, Iacovitti M, Robertson SJ, Mokhtar GA: Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2006; 290:R975-R981.
9. Ninichuk V, Kulkarni O, Clauss S, Anders HJ: Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy. Eur J Med Res 2007; 12: 351-355. (Pubitemid 47365152)
10. Dworkin LD, Hostetter TH, Rennke HG, Brenner BM: Hemodynamic basis for glomerular injury in rats with desoxycorticosterone- salt hypertension. J Clin Invest 1984; 73: 1448-1461.
11. Qi Z, Whitt I, Mehta A, Jin J, Zhao M, Harris RC, Fogo AB, Breyer MD: Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. AmJ Physiol Renal Physiol 2004; 286:F590-F596. (Pubitemid 38233654)
12. Dunn SR, Qi Z, Bottinger EP, Breyer MD, Sharma K: Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int 2004; 65: 1959-1967. (Pubitemid 38591050)
13. Hartner A, Eifert T, Haas CS, Tuysuz C, Hilgers KF, Reinhardt DP, Amann K: Characterization of the renal phenotype in a mouse model of Marfan syndrome. Virchows Arch 2004; 445: 382-388. (Pubitemid 39517764)
14. Sanden SK, Wiggins JE, Goyal M, Riggs LK, Wiggins RC: Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker. J Am Soc Nephrol 2003; 14: 2484-2493. (Pubitemid 37169334)
15. Ziyadeh FN, Hoffman BB, Han DC, Iglesiasde la Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-α antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000; 97: 8015-8020. (Pubitemid 30460765)
16. Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN: The key role of the transforming growth factor-α system in the pathogenesis of diabetic nephropathy. Ren Fail 2001; 23: 471-481. (Pubitemid 32692282)
17. Qi Z, Breyer MD: Measurement of glomerular filtration rate in conscious mice. Methods Mol Biol 2009; 466: 61-72.
18. Eisner C, Faulhaber-Walter R, Wang Y, Leelahavanichkul A, Yuen PS, Mizel D, Star RA, Briggs JP, Levine M, Schnermann J: Major contribution of tubular secretion to creatinine clearance in mice. Kidney Int 2010; 77: 519-526.
19. Powell DW, Bertram CC, Cummins TD, Barati MT, Zheng S, Epstein PN, Klein JB: Renal tubulointerstitial fibrosis in OVE26 type 1 diabetic mice. Nephron Exp Nephrol 2009; 111:e11-e19.
20. Vieyra MB, Heeger PS: Novel aspects of complement in kidney injury. Kidney Int 2010; 77: 495-499.
21. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH: Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury. Kidney Int 2004; 65: 116-128. (Pubitemid 38037496)
22. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH: Macrophages in streptozotocininduced diabetic nephropathy: Potential role in renal fibrosis. Nephrol Dial Transplant 2004; 19: 2987-2996. (Pubitemid 40057619)
23. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, Eichinger F, Nitsche A, Kiss E, Bleich M, Grone HJ, Nelson PJ, Schlondorff D, Cohen CD, Kretzler M: Modular activation of nuclear factor-α B transcriptional programs in human diabetic nephropathy. Diabetes 2006; 55: 2993-3003. (Pubitemid 44923635)
24. Mora C, Navarro JF: Inflammation and diabetic nephropathy. Curr Diab Rep 2006; 6: 463-468. (Pubitemid 44896406)
25. Christensen EI, Verroust PJ: Interstitial fibrosis: Tubular hypothesis versus glomerular hypothesis. Kidney Int 2008; 74: 1233-1236.
26. Abbate M, Zoja C, Remuzzi G: How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006; 17: 2974-2984. (Pubitemid 44707757)
27. Wolf G, Ziyadeh FN: Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 2007; 106: 26-31.